Purpose: Fanconi anemia is a genetically heterogeneous chromosomal breakage disorder exhibiting a high degree of clinical variability. Clinical diagnoses are confirmed by testing patient cells for ...

KING OF PRUSSIA, Pa.--(BUSINESS WIRE)--Genomind – a leading mental health care company – today announced that its flagship pharmacogenetic product, Genomind Professional PGx™, is now available to ...

A breakthrough in the translation of genetic mechanisms and traits that can influence a person’s behavioral predispositions, Genomind Mental Health Map provides the starting point to empower consumers ...

Attardi et al. also claim that the small fraction of transcomplementing clones would not increase in number, even by extending the period of growth in non-selective medium to 10–14 days after fusion, ...

Myriad Genetics, Inc. MYGN recently announced improvements to the GeneSight Psychotropic test, a pharmacogenomic test for drugs used to treat mental illness. The GeneSight report will now contain ...

The Food and Drug Administration has approved a personal genomics test that people can use to find if they metabolize drugs quickly or slowly. The agency said Wednesday that it had approved the ...

Myriad Genetics, Inc. announced that a study published in the Journal of Clinical Psychopharmacology found that the GeneSight® Psychotropic Test significantly reduced psychiatric hospitalizations in ...

"Direct to consumer" genetics tests have soared in popularity in recent years as the cost of genetics sequencing has plummeted. AncestryDNA, Helix, and 23andMe are some of the companies offering the ...

East L.A. diagnostic testing firm Response Genetics announced Monday it had acquired an FDA-cleared test for diagnosing certain cancers. Response Genetics is paying $200,000 in cash and issuing ...

Libby Copeland is the author of The Lost Family: How DNA Testing Is Upending Who We Are. “Have you found an article of clothing with a suspicious stain?” asks the website of one Florida-based company ...